Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison

Cytomegalovirus Seropositivity Predicts a Decline in the T Cell But Not the Antibody Response to Influenza in Vaccinated Older Adults Independent of Type 2 Diabetes Status

(2016) Kamran Haq et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Human influenza viruses and CD8 + T cell responses

(2016) Emma J Grant et al.   Current Opinion in Virology

Superior antigen-specific CD4+T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older

(2014) Robert B Couch et al.   BMC INFECTIOUS DISEASES

Nine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults

(2014) Nolwenn Nougarede et al.   Human Vaccines & Immunotherapeutics

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

(2013) Janet E McElhaney et al.   LANCET INFECTIOUS DISEASES

Cellular immune correlates of protection against symptomatic pandemic influenza

(2013) Saranya Sridhar et al.   NATURE MEDICINE

Safety, immunogenicity, and tolerability of three influenza vaccines in older adults

(2013) David W. Scheifele et al.   Human Vaccines & Immunotherapeutics

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

(2012) Tom M Wilkinson et al.   NATURE MEDICINE

Age of recipient and number of doses differentially impact human B and T cell immune memory responses to HPV vaccination

(2012) Kinga K. Smolen et al.   VACCINE

The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines

(2012) Janet E. McElhaney et al.   VACCINE

Variables to be controlled in the assessment of blood innate immune responses to Toll-like receptor stimulation

(2011) Darren Blimkie et al.   JOURNAL OF IMMUNOLOGICAL METHODS

GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults

(2011) Hayedeh Behzad et al.   JOURNAL OF INFECTIOUS DISEASES

Influenza-Specific T Cells from Older People Are Enriched in the Late Effector Subset and Their Presence Inversely Correlates with Vaccine Response

(2011) Lisa E. Wagar et al.   PLoS One

Influenza vaccine responses in older adults

(2010) Janet E. McElhaney   AGEING RESEARCH REVIEWS

H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses

(2010) Philippe Moris et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age

(2010) D. M. Skowronski et al.   JOURNAL OF INFECTIOUS DISEASES

Clinical and immunologic predictors of influenza illness among vaccinated older adults

(2010) Zainab Shahid et al.   VACCINE

Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults

(2009) Janet E. McElhaney et al.   VACCINE

In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses

(2008) Mary Dawn T. Co et al.   VACCINE